Evidence map›Paper›PMID 31462266›Full record

ArticleFluids and barriers of the CNS2019

Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model.

Louise Delsing, Therése Kallur, Henrik Zetterberg, Ryan Hicks, Jane Synnergren

Open access · goldAbstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. In Vitro Models of the Blood-Brain Barrier.Handbook of experimental pharmacology · 2021
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Louise DelsingDepartment of Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden. louise.delsing@his.se.ORCID http://orcid.org/0000-0003-2899-3801
Therése KallurBioLamina, Sundbyberg, Sweden.
Henrik ZetterbergDepartment of Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden.
Ryan HicksDiscovery Biology, Discovery Sciences, R&D, AstraZeneca, Mölndal, Sweden.
Jane SynnergrenSystems Biology Research Center, School of Bioscience, University of Skövde, Högskolevägen, Box 408, 541 28, Skövde, Sweden.
University of Skövde · SEAstraZeneca (Sweden) · SEBioLamina (Sweden) · SESahlgrenska University Hospital · SE

Funding

Stiftelsen för Kunskaps- och Kompetensutveckling 2014-0289Stiftelsen för Kunskaps- och Kompetensutveckling 2014/0301
6 · The paper itself

Abstract

backgroundHuman induced pluripotent stem cells (hiPSC) hold great promise for use in cell therapy applications and for improved in vitro models of human disease. So far, most hiPSC differentiation protocols to astroglia use undefined, animal-containing culture matrices. Laminins, which play an essential role in the regulation of cell behavior, offer a source of defined, animal-free culture matrix.

methodsIn order to understand how laminins affect astroglia differentiation, recombinant human laminin-521 (LN521), was compared to a murine Engelbreth-Holm-Swarm sarcoma derived laminin (L2020). Astroglia expression of protein and mRNA together with glutamate uptake and protein secretion function, were evaluated. Finally, these astroglia were evaluated in a coculture model of the blood-brain barrier (BBB).

resultsAstroglia of good quality were generated from hiPSC on both LN521 and L2020. However, astroglia differentiated on human LN521 showed higher expression of several astroglia specific mRNAs and proteins such as GFAP, S100B, Angiopoietin-1, and EAAT1, compared to astroglia differentiated on murine L2020. In addition, glutamate uptake and ability to induce expression of junction proteins in endothelial cells were affected by the culture matrix for differentiation.

conclusionOur results suggest that astroglia differentiated on LN521 display an improved phenotype and are suitable for coculture in a hiPSC-derived BBB model. This provides a starting point for a more defined and robust derivation of astroglia for use in BBB coculture models.

Indexed as

Cell DifferentiationAstrocytesBlood-Brain BarrierCell Line, TumorCoculture TechniquesEndothelial CellsGlutamic AcidHumansInduced Pluripotent Stem CellsLamininRNA, MessengerGlutamic AcidLamininlaminin 11 protein, humanRNA, MessengerAstrogliaBlood–brain barrierDifferentiationhiPSCIn vitro modelsLaminin-521

Identifiers

PMID31462266
PMCPMC6714544
OpenAlexW2971226914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.